134 related articles for article (PubMed ID: 26010653)
21. Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males.
Denys D; Van Nieuwerburgh F; Deforce D; Westenberg H
Eur Neuropsychopharmacol; 2006 Aug; 16(6):446-50. PubMed ID: 16427255
[TBL] [Abstract][Full Text] [Related]
22. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder.
Karayiorgou M; Sobin C; Blundell ML; Galke BL; Malinova L; Goldberg P; Ott J; Gogos JA
Biol Psychiatry; 1999 May; 45(9):1178-89. PubMed ID: 10331110
[TBL] [Abstract][Full Text] [Related]
23. Meta-analysis of the association between the catecholamine-O-methyl-transferase gene and obsessive-compulsive disorder.
Azzam A; Mathews CA
Am J Med Genet B Neuropsychiatr Genet; 2003 Nov; 123B(1):64-9. PubMed ID: 14582147
[TBL] [Abstract][Full Text] [Related]
24. The interaction between Comt and Bdnf variants influences obsessive-compulsive-related dysfunctional beliefs.
Alonso P; López-Solà C; Gratacós M; Fullana MA; Segalàs C; Real E; Cardoner N; Soriano-Mas C; Harrison BJ; Estivill X; Menchón JM
J Anxiety Disord; 2013 Apr; 27(3):321-7. PubMed ID: 23602946
[TBL] [Abstract][Full Text] [Related]
25. Association between the COMT locus and obsessive-compulsive disorder in females but not males.
Alsobrook JP; Zohar AH; Leboyer M; Chabane N; Ebstein RP; Pauls DL
Am J Med Genet; 2002 Jan; 114(1):116-20. PubMed ID: 11840516
[TBL] [Abstract][Full Text] [Related]
26. Genetic and pharmacogenetic study of glutamate transporter (SLC1A1) in Iranian patients with obsessive-compulsive disorder.
Abdolhosseinzadeh S; Sina M; Ahmadiani A; Asadi S; Shams J
J Clin Pharm Ther; 2019 Feb; 44(1):39-48. PubMed ID: 30315580
[TBL] [Abstract][Full Text] [Related]
27. Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled Trials.
Dold M; Aigner M; Lanzenberger R; Kasper S
Int J Neuropsychopharmacol; 2015 May; 18(9):. PubMed ID: 25939614
[TBL] [Abstract][Full Text] [Related]
28. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder.
Meira-Lima I; Shavitt RG; Miguita K; Ikenaga E; Miguel EC; Vallada H
Genes Brain Behav; 2004 Apr; 3(2):75-9. PubMed ID: 15005715
[TBL] [Abstract][Full Text] [Related]
29. Obsessive-compulsive disorder and a novel polymorphism adjacent to the oestrogen response element (ERE 6) upstream from the COMT gene.
Kinnear C; Niehaus DJ; Seedat S; Moolman-Smook JC; Corfield VA; Malherbe G; Potgieter A; Lombard C; Stein DJ
Psychiatr Genet; 2001 Jun; 11(2):85-7. PubMed ID: 11525422
[TBL] [Abstract][Full Text] [Related]
30. Comparative efficacy and tolerability of antipsychotics as augmentations in adults with treatment-resistant obsessive-compulsive disorder: A network meta-analysis.
Zhou DD; Zhou XX; Lv Z; Chen XR; Wang W; Wang GM; Liu C; Li DQ; Kuang L
J Psychiatr Res; 2019 Apr; 111():51-58. PubMed ID: 30677645
[TBL] [Abstract][Full Text] [Related]
31. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder.
Karayiorgou M; Altemus M; Galke BL; Goldman D; Murphy DL; Ott J; Gogos JA
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4572-5. PubMed ID: 9114031
[TBL] [Abstract][Full Text] [Related]
32. Aripiprazole augmentation in highly treatment-resistant obsessive-compulsive disorder - experience from a specialty clinic in India.
Hegde A; Kalyani BG; Arumugham SS; Narayanaswamy JC; Math SB; Reddy YC
Int J Psychiatry Clin Pract; 2017 Mar; 21(1):67-69. PubMed ID: 27629160
[TBL] [Abstract][Full Text] [Related]
33. Genetic Polymorphism of the Serotonin Transporter Gene, SLC6A4 rs16965628, Is Associated with Obsessive Compulsive Disorder.
Cengiz M; Okutan SN; Bayoglu B; Sakalli Kani A; Bayar R; Kocabasoglu N
Genet Test Mol Biomarkers; 2015 May; 19(5):228-34. PubMed ID: 25751280
[TBL] [Abstract][Full Text] [Related]
34. Association of HTR1A gene polymorphisms with obsessive-compulsive disorder and its treatment response: the influence of sex and clinical characteristics.
Alizadeh N; Nosrat N; Jahani Z; Ahmadiani A; Asadi S; Shams J
Int J Neurosci; 2019 Mar; 129(3):264-272. PubMed ID: 30232922
[TBL] [Abstract][Full Text] [Related]
35. Risperidone augmentation of specific serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder: report of two cases.
Sun TF; Lin PY; Wu CK
Chang Gung Med J; 2001 Sep; 24(9):587-92. PubMed ID: 11725630
[TBL] [Abstract][Full Text] [Related]
36. Molecular genetics of obsessive-compulsive disorder: a comprehensive meta-analysis of genetic association studies.
Taylor S
Mol Psychiatry; 2013 Jul; 18(7):799-805. PubMed ID: 22665263
[TBL] [Abstract][Full Text] [Related]
37. Association of the low-activity COMT 158Met allele with ADHD and OCD in subjects with velocardiofacial syndrome.
Gothelf D; Michaelovsky E; Frisch A; Zohar AH; Presburger G; Burg M; Aviram-Goldring A; Frydman M; Yeshaya J; Shohat M; Korostishevsky M; Apter A; Weizman A
Int J Neuropsychopharmacol; 2007 Jun; 10(3):301-8. PubMed ID: 16734939
[TBL] [Abstract][Full Text] [Related]
38. Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis.
Lee YH; Kim JH; Song GG
Rheumatol Int; 2015 Jan; 35(1):159-66. PubMed ID: 24951880
[TBL] [Abstract][Full Text] [Related]
39. No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population.
Umehara H; Numata S; Kinoshita M; Watanabe S; Nakaaki S; Sumitani S; Ohmori T
Neuropsychiatr Dis Treat; 2016; 12():611-5. PubMed ID: 27042072
[TBL] [Abstract][Full Text] [Related]
40. Calcium Signaling Pathway Is Associated with the Long-Term Clinical Response to Selective Serotonin Reuptake Inhibitors (SSRI) and SSRI with Antipsychotics in Patients with Obsessive-Compulsive Disorder.
Umehara H; Numata S; Tajima A; Nishi A; Nakataki M; Imoto I; Sumitani S; Ohmori T
PLoS One; 2016; 11(6):e0157232. PubMed ID: 27281126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
